|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu K, Jin M, Xiao L, Liu H and Wei S:
Distinct prognostic values of mRNA expression of glutathione
peroxidases in non-small cell lung cancer. Cancer Manag Res.
10:2997–3005. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jones CM, Brunelli A, Callister ME and
Franks KN: Multimodality treatment of advanced non-small cell lung
cancer: Where are we with the evidence? Curr Surg Rep. 6:52018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
You Q, Guo H and Xu D: Distinct prognostic
values and potential drug targets of ALDH1 isoenzymes in
non-small-cell lung cancer. Drug Des Devel Ther. 9:5087–5097. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen L, Puri R, Lefkowitz EJ and Kakar SS:
Identification of the human pituitary tumor transforming gene
(hPTTG) family: Molecular structure, expression, and chromosomal
localization. Gene. 248:41–50. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vlotides G, Eigler T and Melmed S:
Pituitary tumor-transforming gene: Physiology and implications for
tumorigenesis. Endocr Rev. 28:165–186. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Su X, Chen J, Ni L, Shi W, Shi J, Liu X,
Zhang Y, Gong P, Zhu H and Huang Q: Inhibition of PTTG1 expression
by microRNA suppresses proliferation and induces apoptosis of
malignant glioma cells. Oncol Lett. 12:3463–3471. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xiang W, Wu X, Huang C, Wang M, Zhao X,
Luo G, Li Y, Jiang G, Xiao X and Zeng F: PTTG1 regulated by
miR-146a-3p promotes bladder cancer migration, invasion, metastasis
and growth. Oncotarget. 8:664–678. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang Z, Jin B, Jin Y, Huang S, Niu X, Mao
Z and Xin D: PTTG1, A novel androgen responsive gene is required
for androgen-induced prostate cancer cell growth and invasion. Exp
Cell Res. 350:1–8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li H, Yin C, Zhang B, Sun Y, Shi L, Liu N,
Liang S, Lu S, Liu Y, Zhang J, et al: PTTG1 promotes migration and
invasion of human non-small cell lung cancer cells and is modulated
by miR-186. Carcinogenesis. 34:2145–2155. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li WH, Chang L, Xia YX, Wang L, Liu YY,
Wang YH, Jiang Z, Xiao J and Wang ZR: Knockdown of PTTG1 inhibits
the growth and invasion of lung adenocarcinoma cells through
regulation of TGFB1/SMAD3 signaling. Int J Immunopathol Pharmacol.
28:45–52. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo Y, Shao Y, Chen J, Xu S, Zhang X and
Liu H: Expression of pituitary tumor-transforming 2 in human
glioblastoma cell lines and its role in glioblastoma tumorigenesis.
Exp Ther Med. 11:1847–1852. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Weng W, Ni S, Wang Y, Xu M, Zhang Q, Yang
Y, Wu Y, Xu Q, Qi P, Tan C, et al: PTTG3P promotes gastric tumour
cell proliferation and invasion and is an indicator of poor
prognosis. J Cell Mol Med. 21:3360–3371. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res 45 (W1).
W98–W102. 2017. View Article : Google Scholar
|
|
15
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rhodes DR, Kalyana-Sundaram S, Mahavisno
V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ,
Kincead-Beal C, Kulkarni P, et al: Oncomine 3.0: Genes, pathways,
and networks in a collection of 18,000 cancer gene expression
profiles. Neoplasia. 9:166–180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hou GX, Liu P, Yang J and Wen S: Mining
expression and prognosis of topoisomerase isoforms in
non-small-cell lung cancer by using Oncomine and Kaplan-Meier
plotter. PLoS One. 12:e01745152017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lou W, Chen J, Ding B, Chen D, Zheng H,
Jiang D, Xu L, Bao C, Cao G and Fan W: Identification of
invasion-metastasis-associated microRNAs in hepatocellular
carcinoma based on bioinformatic analysis and experimental
validation. J Transl Med. 16:2662018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lou W, Liu J, Ding B, Chen D, Xu L, Ding
J, Jiang D, Zhou L, Zheng S and Fan W: Identification of potential
miRNA-mRNA regulatory network contributing to pathogenesis of
HBV-related HCC. J Transl Med. 17:72019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Győrffy B, Surowiak P, Budczies J and
Lánczky A: Online survival analysis software to assess the
prognostic value of biomarkers using transcriptomic data in
non-small-cell lung cancer. PLoS One. 8:e822412013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fuertes M, Sapochnik M, Tedesco L, Senin
S, Attorresi A, Ajler P, Carrizo G, Cervio A, Sevlever G, Bonfiglio
JJ, et al: Protein stabilization by RSUME accounts for PTTG
pituitary tumor abundance and oncogenicity. Endocr Relat Cancer.
25:665–676. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Read ML, Fong JC, Modasia B, Fletcher A,
Imruetaicharoenchoke W, Thompson RJ, Nieto H, Reynolds JJ, Bacon A,
Mallick U, et al: Elevated PTTG and PBF predicts poor patient
outcome and modulates DNA damage response genes in thyroid cancer.
Oncogene. 36:5296–5308. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao H, Zhong F, Xie J, Peng J and Han Z:
PTTG promotes invasion in human breast cancer cell line by
upregulating EMMPRIN via FAK/Akt/mTOR signaling. Am J Cancer Res.
6:425–439. 2016.PubMed/NCBI
|
|
25
|
Wang X, Duan W, Li X, Liu J, Li D, Ye L,
Qian L, Yang A, Xu Q, Liu H, et al: PTTG regulates the metabolic
switch of ovarian cancer cells via the c-myc pathway. Oncotarget.
6:40959–40969. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kakar SS and Malik MT: Suppression of lung
cancer with siRNA targeting PTTG. Int J Oncol. 29:387–395.
2006.PubMed/NCBI
|
|
27
|
Mu YM, Oba K, Yanase T, Ito T, Ashida K,
Goto K, Morinaga H, Ikuyama S, Takayanagi R and Nawata H: Human
pituitary tumor transforming gene (hPTTG) inhibits human lung
cancer A549 cell growth through activation of p21(WAF1/CIP1).
Endocr J. 50:771–781. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rehfeld N, Geddert H, Atamna A, Rohrbeck
A, Garcia G, Kliszewski S, Neukirchen J, Bruns I, Steidl U, Fenk R,
et al: The influence of the pituitary tumor transforming gene-1
(PTTG-1) on survival of patients with small cell lung cancer and
non-small cell lung cancer. J Carcinog. 5:42006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shah PP, Fong MY and Kakar SS: PTTG
induces EMT through integrin αVβ3-focal adhesion kinase signaling
in lung cancer cells. Oncogene. 31:3124–3135. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Honda S, Hayashi M, Kobayashi Y, Ishikawa
Y, Nakagawa K and Tsuchiya E: A role for the pituitary
tumor-transforming gene in the genesis and progression of non-small
cell lung carcinomas. Anticancer Res. 23:3775–3782. 2003.PubMed/NCBI
|
